Cost: Free

Start Date: 02/20/2021

Expiration Date: 02/20/2021

Target Audience: Primary Care

Format: Rebroadcast Virtual Symposium

Estimated Time To Complete CME Activity: 6.25 hours

6.25 AMA PRA Category 1 Credits TM
6.25 AANP Contact Hours including 2.75 pharmacology hours

Hardware/Software Requirements: Any web browser

Date: Sat, Feb 20th 2021 09:00 am – 06:00 pm PST

Add To Calendar

Start Time 9:00 AM PST

Registration Fee

There is no registration fee for this activity.

Special Accommodations

NACE fully complies with the legal requirements of the Americans with Disabilities Act. Any activity registrant who feels s/he may need accommodations based on the impact of a disability should contact NACE to discuss your specific needs.

Program Summary

Join Dr. Gregg Sherman and Ashlyn Smith online for this live virtual broadcast and stay on track to fulfill your CME/CE requirements from the comfort of your home.

Primary care providers face complex challenges everyday in their busy practices. With rapid changes in medicine, staying informed about new developments can be equally challenging. Our goal in this CME/CE activity is to help you hone your skills in the diagnosis and management of patients with varied conditions you are likely encountering in your practice.

Utilizing an interactive, moderator led format, this program will present discussions with national thought leaders, who as clinicians themselves, understand the challenges you face every day as a primary care provider. Our faculty will be at your disposal to provide evidence-based science, current treatment guidelines, discuss challenging cases, and provide answers for you that can ultimately lead to better health care for your patients. The presentations will include several interactive cases and discussion sessions to keep you actively learning.

Learning Objectives
Upon completion of this activity, learners should be able to:


9:00 – 9:05 am EST
Welcome Remarks
Gregg Sherman, MD, and Ashlyn Smith, PA-C

9:05 – 10:05 EST
COVID-19 Therapeutics: Keeping Up with a Moving Target
Paul G. Auwaerter, MD, MBA, FIDSA  and Charles Vega, MD, FAAFP
Moderator: Ashlyn Smith, PA-C

10:05 – 10:20 EST

10:20 – 11:20 EST
Presentation Theater: Understanding GLP-1 RA in the Evolving T2D Treatment Landscape
(CME not offered)

11:20 – 11:30 EST

11:30 – 12:35 pm EST
C. Difficile Infection: Evolution of an Infection and Treatment
Paul Feuerstadt, MD, FACG, AGAF
Moderator: Gregg Sherman, MD

12:35 – 1:05 EST
Lunch Break

1:05 – 1:35 EST
Using Natriuretic Peptides Effectively in Heart Failure
James L. Januzzi, MD
Moderator: Ashlyn Smith, PA-C

1:35 – 1:45 EST

1:45 – 2:45 EST
Safely Diagnosing and Managing Overactive Bladder: What You Need to Know
Matt T. Rosenberg, MD and Diane K. Newman, DNP, CRNP, FAAN, BCB-PMD
Moderator: Gregg Sherman, MD

2:45 – 2:55 EST

2:55 – 3:40 EST
COVID-19 Update
Neil Skolnik, MD and Leana Wen, MD, MSc

3:40 – 3:50 EST

3:50 – 4:50 EST
Optimizing Management of Chronic Idiopathic Constipation by Focusing on the Patient
Moderator: Ashlyn Smith, PA-C

4:50 – 5:00 EST

5:00 – 6:00 EST
Beyond Bronchodilation: Improving Outcomes in COPD
Franck Rahaghi, MD, MHS
Moderator: Gregg Sherman, MD

6:00 EST
Closing Remarks
Moderator: Gregg Sherman, MD

*Subject to change

Paul G. Auwaerter, MD, MBA, FIDSA
Past President of the Infectious Diseases Society of America (IDSA)
Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore, MD

Division Director, Gastroenterology, Hepatology, And Nutrition
Dan And Lillie Sterling Professor of Medicine
University of Texas Health Science Center at Houston
Houston, TX

Paul Feuerstadt, MD, FACG, AGAF
Assistant Clinical Professor of Medicine
Yale University School of Medicine
Attending Physician
Gastroenterology Center of Connecticut
Hamden, CT

James L. Januzzi, MD
Cardiologist, Massachusetts General Hospital
Hutter Family Professor of Medicine at Harvard Medical School
Trustee, American College of Cardiology
Associate Editor, Journal of the American College of Cardiology
Senior Medical Director, Baim Institute for Clinical Research
Boston, MA

Franck Rahaghi, MD, MHS
Chairman, Dept. of Pulmonary Medicine
Director of Alpha-1 Foundation Clinical Resource Center
Cleveland Clinic Florida
Weston, FL

Matt T. Rosenberg, MD
Section Editor
Urology, International Journal of Clinical Practice
Director, Mid-Michigan Health Centers
Jackson, MI

Charles Vega, MD, FAAFP
Health Sciences Clinical Professor
UC Irvine Department of Family Medicine
Assistant Dean for Culture and Community Education
UC Irvine School of Medicine
UC Irvine Program in Medical Education for the Latino Community
Irvine, CA

Leana S. Wen, MD, MSc
Visiting Professor, Health Policy and Management
Distinguished Fellow, Fitzhugh Mullan Institute for Health Workforce Equity
George Washington University School of
Public Health
Washington, DC

Gregg Sherman, MD
Course Director
Chief Medical Officer
National Association for Continuing Education
Plantation, FL

Ashlyn Smith, PA-C
Endocrinology Associates, P.A.
President, American Society of Endocrine
Physician Assistants
Adjunct Assistant Professor, Midwestern University
Scottsdale, AZ

Planning Committee
Sandy Bihlmeyer, MEd
Senior Project Manager
National Association for Continuing Education
Plantation, FL

Michelle Frisch, MPH, CHCP
Vice President, Operations
National Association for Continuing Education
Plantation, FL

Angela Golden, DNP, FNP-C, FAANP
Family Nurse Practitioner
NP Obesity Treatment Clinic and NP from Home, LLC
Assistant Professor (Ret), Northern Arizona University
Past President, American Association of Nurse Practitioners
Munds Park, AZ

Daniela Hiedra
Activity Director
National Association for Continuing Education
Plantation, FL

Joshua F. Kilbridge
President and Creative Director
Kilbridge Associates
San Francisco, CA

Laurl Ann Matey, MSN, RN, CHPN
Medical Director
National Association for Continuing Education
Plantation, FL

DKB Staff and Planning Committee

Faith Rogers, BS
Assistant Project Alchemist

Rachel Deerr, BS
Associate Director, Project Alchemist

Stan Pogroszewski, JD
Chief Operating Officer
Director of Compliance

Lesley Simon, BA
Editorial Manager

Sponsored and Certified By
National Association for Continuing Education

NACE AANP Approval
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 6.25 contact hours (which includes 2.0 pharmacology hours).

NACE CME Accreditation

Accreditation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
The National Association for Continuing Education designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Policy on Faculty and Provider Disclosure

Educational programs sponsored by the National Association for Continuing Education (NACE) must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a NACE-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity. Any potential conflicts of interest will be resolved prior to the activity.

Per the ACCME, a Commercial Interest is defined as an entity producing, marketing, re-selling or distributing health care goods or services consumed by or used on, patients. Providers of clinical service directly to patients are not considered to be commercial interests - unless the provider of the clinical service is owned, or controlled by, a defined commercial interest.

Commercial Support
This educational activity is supported in part by an educational grant from Astellas Pharma Global Development, Inc.; an educational grant from Ferring Pharmaceuticals Inc.; an educational grant from Gilead Sciences, Inc.; an educational grant from Grifols; an independent medical education grant from Regeneron Pharmaceuticals, Inc.; an educational grant from Takeda Pharmaceuticals U.S.A., Inc.; and an educational grant from Roche Diagnostics.